LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Capristano, Silvia"
  2. AU=Yamamoto Yuki

Search results

Result 1 - 10 of total 10

Search options

  1. Article ; Online: Pharmacogenetic variability of tuberculosis biomarkers in native and mestizo Peruvian populations.

    Jaramillo-Valverde, Luis / Levano, Kelly S / Tarazona, David D / Capristano, Silvia / Sanchez, Cesar / Poterico, Julio A / Tarazona-Santos, Eduardo / Guio, Heinner

    Pharmacology research & perspectives

    2024  Volume 12, Issue 3, Page(s) e1179

    Abstract: In Peru, 29 292 people were diagnosed with tuberculosis in 2022. Although tuberculosis treatments are effective, 3.4%-13% are associated with significant adverse drug reactions, with drug-induced liver injury (DILI) considered the most predominant. Among ...

    Abstract In Peru, 29 292 people were diagnosed with tuberculosis in 2022. Although tuberculosis treatments are effective, 3.4%-13% are associated with significant adverse drug reactions, with drug-induced liver injury (DILI) considered the most predominant. Among the first-line antituberculosis drugs, isoniazid is the main drug responsible for the appearance of DILI. In liver, isoniazid (INH) is metabolized by N-acetyltransferase-2 (NAT2) and cytochrome P450 2E1 (CYP2E1). Limited information exists on genetic risk factors associated with the presence of DILI to antituberculosis drugs in Latin America, and even less is known about these factors in the native and mestizo Peruvian population. The aim of this study was to determine the prevalence of NAT2 and CYP2E1 genotypes in native and mestizo population. An analytical cross-sectional analysis was performed using genetic data from mestizo population in Lima and native participants from south of Peru. NAT2 metabolizer was determined as fast, intermediate and slow, and CYP2E1 genotypes were classified as c1/c1, c1/c2 and c2/c2, from molecular tests and bioinformatic analyses. Of the 472 participants, 36 and 6 NAT2 haplotypes were identified in the mestizo and native population, respectively. In mestizo population, the most frequent NAT2*5B and NAT2*7B haplotypes were associated with DILI risk; while in natives, NAT2*5G and NAT2*13A haplotypes were associated with decreased risk of DILI. For CYP2E1, c1/c1 and c1/c2 genotypes are the most frequent in natives and mestizos, respectively. The linkage disequilibrium of NAT2 single nucleotide polymorphisms (SNPs) was estimated, detecting a block between all SNPs natives. In addition, a block between rs1801280 and rs1799929 for NAT2 was detected in mestizos. Despite the limitations of a secondary study, it was possible to report associations between NAT2 and CYP2E alleles with Peruvian native and mestizo by prevalence ratios. The results of this study will help the development of new therapeutic strategies for a Tuberculosis efficient control between populations.
    MeSH term(s) Humans ; Peru ; Arylamine N-Acetyltransferase/genetics ; Antitubercular Agents/therapeutic use ; Antitubercular Agents/adverse effects ; Female ; Male ; Adult ; Middle Aged ; Tuberculosis/genetics ; Tuberculosis/drug therapy ; Isoniazid/adverse effects ; Isoniazid/therapeutic use ; Cytochrome P-450 CYP2E1/genetics ; Cross-Sectional Studies ; Chemical and Drug Induced Liver Injury/genetics ; Young Adult ; Genotype ; Indians, South American/genetics ; Biomarkers ; Adolescent ; Aged ; Pharmacogenetics
    Chemical Substances Arylamine N-Acetyltransferase (EC 2.3.1.5) ; Antitubercular Agents ; NAT2 protein, human (EC 2.3.1.5) ; Isoniazid (V83O1VOZ8L) ; Cytochrome P-450 CYP2E1 (EC 1.14.13.-) ; Biomarkers
    Language English
    Publishing date 2024-04-26
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2740389-0
    ISSN 2052-1707 ; 2052-1707
    ISSN (online) 2052-1707
    ISSN 2052-1707
    DOI 10.1002/prp2.1179
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Antigen-Induced IL-1RA Production Discriminates Active and Latent Tuberculosis Infection.

    Sanchez, Cesar / Jaramillo-Valverde, Luis / Capristano, Silvia / Solis, Gilmer / Soto, Alonso / Valdivia-Silva, Julio / Poterico, Julio A / Guio, Heinner

    Microorganisms

    2023  Volume 11, Issue 6

    Abstract: The IGRA (Interferon Gamma Release Assays) test is currently the standard specific test ... ...

    Abstract The IGRA (Interferon Gamma Release Assays) test is currently the standard specific test for
    Language English
    Publishing date 2023-05-25
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2720891-6
    ISSN 2076-2607
    ISSN 2076-2607
    DOI 10.3390/microorganisms11061385
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Differential expression of circulating micro-RNAs in patients with active and latent tuberculosis.

    Yareta, José / Galarza, Marco / Capristano, Silvia / Pellón, Oscar / Sánchez, César / Ballon, Jorge / Guio, Heinner

    Revista peruana de medicina experimental y salud publica

    2020  Volume 37, Issue 1, Page(s) 51–56

    Abstract: Objectives: To analyze the differential expression of miR-21, miR-29a, miR-99b and miR-155 in serum samples from patients with latent tuberculosis (TB) and active TB compared to healthy controls.: Mate rials and methods: We used 28 serum samples (9 ... ...

    Title translation Expresión diferencial de micro-ARN circulantes en pacientes con tuberculosis activa y latente.
    Abstract Objectives: To analyze the differential expression of miR-21, miR-29a, miR-99b and miR-155 in serum samples from patients with latent tuberculosis (TB) and active TB compared to healthy controls.
    Mate rials and methods: We used 28 serum samples (9 with active TB, 10 with latent TB and 9 healthy con trols) for the analysis of gene expression by RT-qPCR with Primers and TaqMan probes. The differential expression was calculated by the Livak method using a normalizing gene (RNU-48).
    Results: Overex pression of miR-155 was found in people with latent tuberculosis, compared to healthy controls (0.63 vs. 0.01; p value = 0.032).
    Conclusion: The miR-155 could be considered a biomarker to differentiate latent TB from active disease. Studies with larger sample sizes are required to corroborate the findings.
    MeSH term(s) Biomarkers/blood ; Case-Control Studies ; Gene Expression ; Humans ; Latent Tuberculosis/blood ; Latent Tuberculosis/therapy ; MicroRNAs/blood ; MicroRNAs/genetics ; Tuberculosis/blood ; Tuberculosis/therapy
    Chemical Substances Biomarkers ; MicroRNAs
    Language English
    Publishing date 2020-06-08
    Publishing country Peru
    Document type Journal Article
    ZDB-ID 2120092-0
    ISSN 1726-4642 ; 1726-4642
    ISSN (online) 1726-4642
    ISSN 1726-4642
    DOI 10.17843/rpmesp.2020.371.4468
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Neutralization of SARS-CoV-2 (lineage B.1.1) by hyperimmune llama (Lama glama) serum in vero cell culture.

    Yaniro, Verónica / Capristano, Silvia / Bailon, Henri / Lévano, Juan / Galarza, Marco / García, David / Cáceres, Omar / Padilla, Carlos / Montejo, Harrison / García, Paquita / Celis, Mary / Seraylan, Silvia / Garayar, Yessica / Palomino, Miryam

    Revista peruana de medicina experimental y salud publica

    2023  Volume 40, Issue 3, Page(s) 287–296

    Abstract: Objective.: To evaluate the serological antibody response of a llama (Lama glama) to SARS-CoV-2 (B.1.1 lineage) immunization and the neutralizing capacity of hyperimmune llama serum against SARS-CoV-2 virus (B.1.1 lineage) in Vero cells.: Materials ... ...

    Title translation Neutralización del virus SARS-CoV-2 (linaje B.1.1) por suero hiperinmune de llama (Lama glama) en cultivo de células Vero.
    Abstract Objective.: To evaluate the serological antibody response of a llama (Lama glama) to SARS-CoV-2 (B.1.1 lineage) immunization and the neutralizing capacity of hyperimmune llama serum against SARS-CoV-2 virus (B.1.1 lineage) in Vero cells.
    Materials and methods.: A llama was immunized with inactivated SARS-CoV-2 (B.1.1 lineage). Serum samples were analyzed to evaluate the level of antibodies by ELISA, as well as reactivity to SARS-CoV-2 antigens by Western Blot. In addition, viral neutralization in cell cultures was assessed by the Plate Reduction Neutralization Test (PRNT).
    Results: . Seroreactivity increased in the immunized llama from week 4 onwards. Antibody titers were the highest after the seventh immunization booster. Western blot results confirmed the positive ELISA findings, and immune serum antibodies recognized several viral proteins. The neutralization assay (PRNT) showed visible viral neutralization, which was in accordance with the ELISA and Western Blot results.
    Conclusions.: The findings suggest that hyperimmune llama serum could constitute a source of therapeutic antibodies against SARS-CoV-2 infections (lineage B.1.1), and should be studied in further research.
    MeSH term(s) Animals ; Chlorocebus aethiops ; Humans ; SARS-CoV-2 ; COVID-19 ; Vero Cells ; Camelids, New World ; Antibodies, Viral ; Cell Culture Techniques
    Chemical Substances Antibodies, Viral
    Language English
    Publishing date 2023-09-27
    Publishing country Peru
    Document type Journal Article
    ZDB-ID 2120092-0
    ISSN 1726-4642 ; 1726-4642
    ISSN (online) 1726-4642
    ISSN 1726-4642
    DOI 10.17843/rpmesp.2023.403.12509
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: GSTT1/GSTM1

    Jaramillo-Valverde, Luis / Levano, Kelly S / Tarazona, David D / Vasquez-Dominguez, Andres / Toledo-Nauto, Anel / Capristano, Silvia / Sanchez, Cesar / Tarazona-Santos, Eduardo / Ugarte-Gil, Cesar / Guio, Heinner

    International journal of molecular sciences

    2022  Volume 23, Issue 19

    Abstract: In Peru, 24,581 people were diagnosed with tuberculosis (TB) in 2020. Although TB treatments are effective, 3.4-13% are associated with significant adverse drug reactions (ADRs), with drug-induced liver injury (DILI) considered the most predominant. ... ...

    Abstract In Peru, 24,581 people were diagnosed with tuberculosis (TB) in 2020. Although TB treatments are effective, 3.4-13% are associated with significant adverse drug reactions (ADRs), with drug-induced liver injury (DILI) considered the most predominant. Among the first-line antituberculosis drugs, isoniazid (INH) is the main drug responsible for the appearance of DILI. In the liver, INH is metabolized by the enzymes N-acetyltransferase-2 (NAT2), cytochrome P450 2E1 (CYP2E1), and glutathione S-transferase (GST) with two isoforms, GSTT1 and GSTM1. Based on previous studies, we hypothesized that interactions between the
    MeSH term(s) Antitubercular Agents/adverse effects ; Arylamine N-Acetyltransferase/genetics ; Chemical and Drug Induced Liver Injury/etiology ; Chemical and Drug Induced Liver Injury/genetics ; Cross-Sectional Studies ; Cytochrome P-450 CYP2E1/genetics ; Genetic Predisposition to Disease ; Genotype ; Glutathione Transferase/genetics ; Humans ; Isoniazid ; Peru/epidemiology ; Polymorphism, Genetic ; Tuberculosis/drug therapy ; Tuberculosis/genetics
    Chemical Substances Antitubercular Agents ; Cytochrome P-450 CYP2E1 (EC 1.14.13.-) ; Arylamine N-Acetyltransferase (EC 2.3.1.5) ; NAT2 protein, human (EC 2.3.1.5) ; glutathione S-transferase T1 (EC 2.5.1.-) ; Glutathione Transferase (EC 2.5.1.18) ; glutathione S-transferase M1 (EC 2.5.1.18) ; Isoniazid (V83O1VOZ8L)
    Language English
    Publishing date 2022-09-20
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms231911028
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Comparative Profiling of Circulating Exosomal Small RNAs Derived From Peruvian Patients With Tuberculosis and Pulmonary Adenocarcinoma.

    Guio, Heinner / Aliaga-Tobar, Victor / Galarza, Marco / Pellon-Cardenas, Oscar / Capristano, Silvia / Gomez, Henry L / Olivera, Mivael / Sanchez, Cesar / Maracaja-Coutinho, Vinicius

    Frontiers in cellular and infection microbiology

    2022  Volume 12, Page(s) 909837

    Abstract: Tuberculosis (TB) is one of the most fatal infectious diseases, caused by the aerobic ... ...

    Abstract Tuberculosis (TB) is one of the most fatal infectious diseases, caused by the aerobic bacteria
    MeSH term(s) Adenocarcinoma/genetics ; Adenocarcinoma/pathology ; Cell-Free Nucleic Acids ; Humans ; MicroRNAs/metabolism ; Mycobacterium tuberculosis/genetics ; Mycobacterium tuberculosis/metabolism ; Peru ; Tuberculosis/diagnosis
    Chemical Substances Cell-Free Nucleic Acids ; MicroRNAs
    Language English
    Publishing date 2022-06-30
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2619676-1
    ISSN 2235-2988 ; 2235-2988
    ISSN (online) 2235-2988
    ISSN 2235-2988
    DOI 10.3389/fcimb.2022.909837
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: NAT2 and CYP2E1 polymorphisms and antituberculosis drug-induced hepatotoxicity in Peruvian patients.

    Jaramillo-Valverde, Luis / Levano, Kelly S / Tarazona, David D / Capristano, Silvia / Zegarra-Chapoñan, Roberto / Sanchez, Cesar / Yufra-Picardo, Velia M / Tarazona-Santos, Eduardo / Ugarte-Gil, Cesar / Guio, Heinner

    Molecular genetics & genomic medicine

    2022  Volume 10, Issue 8, Page(s) e1987

    Abstract: Background: In Peru, 32,970 people were diagnosed with tuberculosis (TB) in 2019. Although TB treatment is effective, 3.4%-13% is associated with significant adverse drug reactions (ADR), considering drug-induced liver injury (DILI) as the most ... ...

    Abstract Background: In Peru, 32,970 people were diagnosed with tuberculosis (TB) in 2019. Although TB treatment is effective, 3.4%-13% is associated with significant adverse drug reactions (ADR), considering drug-induced liver injury (DILI) as the most prevalent. Among the first-line anti-TB drugs, isoniazid (INH) is primarily responsible for the occurrence of DILI. INH is metabolized in the liver by the enzymes N-acetyltransferase-2 (NAT2) and Cytochrome P450 2E1 (CYP2E1). Based on the previous studies, we hypothesized that the interactions between slow CYP2E1 genotype and NAT2 slow acetylators will induce DILI in TB patients.
    Methods: In this cross-sectional study, all 377 participants completed their anti-TB treatment, and we genotyped SNPs: rs1041983, rs1801280, rs1799929, rs1799930, rs1208, and rs1799931 for NAT2 and rs3813867 and rs2031920 for CYP2E1.
    Results: We found that rapid, intermediate, and slow NAT2 acetylator were 15%, 38%, and 47%, respectively, in the general population. Intermediate NAT2 acetylator is the least prevalent among patients with adverse reactions (p = 0.024). We did not confirm our hypothesis, however, we found that the combination of intermediate NAT2 acetylators and CYP2E1 c1/c1 genotype significantly protected (OR = 0.16; p = 0.049) against the development of DILI in our population.
    Conclusion: We propose that the presence of NAT2 intermediate and CYP2E1 c1/c1 genotype could help in therapeutic drug monitoring, and optimize its therapeutic benefits while minimizing its risk for side effects or toxicity.
    MeSH term(s) Antitubercular Agents/adverse effects ; Arylamine N-Acetyltransferase/genetics ; Chemical and Drug Induced Liver Injury/etiology ; Chemical and Drug Induced Liver Injury/genetics ; Cross-Sectional Studies ; Cytochrome P-450 CYP2E1/genetics ; Humans ; Peru ; Polymorphism, Single Nucleotide ; Tuberculosis/drug therapy ; Tuberculosis/genetics
    Chemical Substances Antitubercular Agents ; Cytochrome P-450 CYP2E1 (EC 1.14.13.-) ; Arylamine N-Acetyltransferase (EC 2.3.1.5) ; NAT2 protein, human (EC 2.3.1.5)
    Language English
    Publishing date 2022-06-24
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2734884-2
    ISSN 2324-9269 ; 2324-9269
    ISSN (online) 2324-9269
    ISSN 2324-9269
    DOI 10.1002/mgg3.1987
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: CXCR4 Knockdown Via CRISPR/CAS9 in a Tumor-Associated Macrophage Model Decreases Human Breast Cancer Cell Migration.

    Jaramillo-Valverde, Luis / Levano, Kelly S / Capristano, Silvia / Tarazona, David D / Cisneros, Alberto / Yufra-Picardo, Velia M / Valdivia-Silva, Julio / Guio, Heinner

    Cureus

    2021  Volume 13, Issue 12, Page(s) e20842

    Abstract: Introduction Breast cancer is the leading cause of cancer-related deaths in women worldwide with the majority of deaths due to metastasis. The development of metastasis is closely related to the tumor microenvironment where tumor-associated macrophages ( ... ...

    Abstract Introduction Breast cancer is the leading cause of cancer-related deaths in women worldwide with the majority of deaths due to metastasis. The development of metastasis is closely related to the tumor microenvironment where tumor-associated macrophages (TAMs) are the main immune cell component playing a crucial role in tumor migration. Key players in tumor progression, metastasis and survival are the receptor CXCR4 and its ligand CXCL12. CXCR4 is expressed in multiple cell types including macrophages and breast cancer cells. Many studies have focus on the role of CXCR4 expressed in breast cancer cells. Methods In this study, we investigated the role of CXCR4 expressed in TAMs on breast cancer cell migration by reducing CXCR4 expression via CRISPR-CAS9 system in differentiated THP-1 cells (a TAMs model). Results According to wound healing migration assay, MCF7 cancer cells co-cultured with genetically edited dTHP-1 cells have a lower migration rate as compared to MCF7 cancer cells co-cultured with unedited and dTHP-1 cells. Conclusion The study demonstrates the role of CXCR4 on breast cancer cell migration through TAM-cancer cell crosstalk.
    Language English
    Publishing date 2021-12-30
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2747273-5
    ISSN 2168-8184
    ISSN 2168-8184
    DOI 10.7759/cureus.20842
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Allelic and genotypic frequencies of NAT2, CYP2E1, and AADAC genes in a cohort of Peruvian tuberculosis patients.

    Levano, Kelly S / Jaramillo-Valverde, Luis / Tarazona, David D / Sanchez, Cesar / Capristano, Silvia / Vásquez-Loarte, Tania / Solari, Lely / Mendoza-Ticona, Alberto / Soto, Alonso / Rojas, Christian / Zegarra-Chapoñan, Roberto / Guio, Heinner

    Molecular genetics & genomic medicine

    2021  Volume 9, Issue 10, Page(s) e1764

    Abstract: Background: We determined the frequency of genetic polymorphisms in three anti-TB drug metabolic proteins previously reported: N-acetyltransferase 2 (NAT2), cytochrome P450 2E1 (CYP2E1), and arylacetamide deacetylase (AADAC) within a Peruvian population ...

    Abstract Background: We determined the frequency of genetic polymorphisms in three anti-TB drug metabolic proteins previously reported: N-acetyltransferase 2 (NAT2), cytochrome P450 2E1 (CYP2E1), and arylacetamide deacetylase (AADAC) within a Peruvian population in a cohort of TB patients.
    Methods: We genotyped SNPs rs1041983, rs1801280, rs1799929, rs1799930, rs1208, and rs1799931 for NAT2; rs3813867 and rs2031920 for CYP2E1; and rs1803155 for AADAC in 395 participants completed their antituberculosis treatment.
    Results: Seventy-four percent of the participants are carriers of slow metabolizer genotypes: NAT2*5, NAT2*6, and NAT2*7, which increase the sensitivity of INH at low doses and increase the risk of drug-induced liver injuries. Sixty-four percent are homozygous for the wild-type CYP2E1*1A allele, which could increase the risk of hepatotoxicity. However, 16% had a NAT2 fast metabolizer phenotype which could increase the risk of acquiring resistance to INH, thereby increasing the risk of multidrug-resistant (MDR) or treatment failure. The frequency of rs1803155 (AADAC*2 allele) was higher (99.9%) in Peruvians than in European American, African American, Japanese, and Korean populations.
    Conclusions: This high prevalence of slow metabolizers for isoniazid in the Peruvian population should be further studied and considered to help individualize drug regimens, especially in countries with a great genetic diversity like Peru. These data will help the Peruvian National Tuberculosis Control Program develop new strategies for therapies.
    MeSH term(s) Alleles ; Arylamine N-Acetyltransferase/genetics ; Carboxylic Ester Hydrolases/genetics ; Cytochrome P-450 CYP2E1/genetics ; Gene Frequency ; Genetic Association Studies ; Genetic Predisposition to Disease ; Genotype ; Humans ; Linkage Disequilibrium ; Peru ; Phenotype ; Polymorphism, Single Nucleotide ; Tuberculosis/etiology
    Chemical Substances Cytochrome P-450 CYP2E1 (EC 1.14.13.-) ; Arylamine N-Acetyltransferase (EC 2.3.1.5) ; NAT2 protein, human (EC 2.3.1.5) ; AADAC protein, human (EC 3.1.1.-) ; Carboxylic Ester Hydrolases (EC 3.1.1.-)
    Language English
    Publishing date 2021-09-12
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2734884-2
    ISSN 2324-9269 ; 2324-9269
    ISSN (online) 2324-9269
    ISSN 2324-9269
    DOI 10.1002/mgg3.1764
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Evolutionary genomic dynamics of Peruvians before, during, and after the Inca Empire.

    Harris, Daniel N / Song, Wei / Shetty, Amol C / Levano, Kelly S / Cáceres, Omar / Padilla, Carlos / Borda, Víctor / Tarazona, David / Trujillo, Omar / Sanchez, Cesar / Kessler, Michael D / Galarza, Marco / Capristano, Silvia / Montejo, Harrison / Flores-Villanueva, Pedro O / Tarazona-Santos, Eduardo / O'Connor, Timothy D / Guio, Heinner

    Proceedings of the National Academy of Sciences of the United States of America

    2018  Volume 115, Issue 28, Page(s) E6526–E6535

    Abstract: Native Americans from the Amazon, Andes, and coastal geographic regions of South America have a rich cultural heritage but are genetically understudied, therefore leading to gaps in our knowledge of their genomic architecture and demographic history. In ... ...

    Abstract Native Americans from the Amazon, Andes, and coastal geographic regions of South America have a rich cultural heritage but are genetically understudied, therefore leading to gaps in our knowledge of their genomic architecture and demographic history. In this study, we sequence 150 genomes to high coverage combined with an additional 130 genotype array samples from Native American and mestizo populations in Peru. The majority of our samples possess greater than 90% Native American ancestry, which makes this the most extensive Native American sequencing project to date. Demographic modeling reveals that the peopling of Peru began ∼12,000 y ago, consistent with the hypothesis of the rapid peopling of the Americas and Peruvian archeological data. We find that the Native American populations possess distinct ancestral divisions, whereas the mestizo groups were admixtures of multiple Native American communities that occurred before and during the Inca Empire and Spanish rule. In addition, the mestizo communities also show Spanish introgression largely following Peruvian Independence, nearly 300 y after Spain conquered Peru. Further, we estimate migration events between Peruvian populations from all three geographic regions with the majority of between-region migration moving from the high Andes to the low-altitude Amazon and coast. As such, we present a detailed model of the evolutionary dynamics which impacted the genomes of modern-day Peruvians and a Native American ancestry dataset that will serve as a beneficial resource to addressing the underrepresentation of Native American ancestry in sequencing studies.
    MeSH term(s) History, Ancient ; Humans ; Indians, South American/genetics ; Indians, South American/history ; Models, Genetic ; Peru ; Population Dynamics
    Language English
    Publishing date 2018-06-26
    Publishing country United States
    Document type Historical Article ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.1720798115
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top